4//SEC Filing
ARENA PHARMACEUTICALS INC 4
Accession 0001166280-14-000001
CIK 0001080709operating
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 7:18 PM ET
Size
9.2 KB
Accession
0001166280-14-000001
Insider Transaction Report
Form 4
LIEF JACK
DirectorChairman, President and CEO
Transactions
- Sale
Common Stock
2014-01-17$7.81/sh−100,000$781,260→ 583,704 total - Exercise/Conversion
Common Stock
2014-01-17$6.00/sh+100,000$600,000→ 683,704 total - Exercise/Conversion
Employee Stock Option (right to buy)
2014-01-17−100,000→ 0 totalExercise: $6.00From: 2004-01-18Exp: 2014-01-18→ Common Stock (100,000 underlying)
Footnotes (4)
- [F1]The amount includes shares purchased under Arena's employee stock purchase plan prior to the reported transaction.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F3]This price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.67 and $7.92 per share, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The options were exercisable upon grant, but vested in four approximately equal annual installments beginning on January 18, 2005.
Documents
Issuer
ARENA PHARMACEUTICALS INC
CIK 0001080709
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001080709
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 7:18 PM ET
- Size
- 9.2 KB